Close Menu

NEW YORK – Wake Forest Baptist Health on Tuesday said the National Cancer Institute has awarded a $2.5 million grant to a program using organoids to research how genomic changes in aggressive cancers impact patients' responses to treatment.

The funds will support the work of the Wake Forest Organoid Research Center, which aims to advance personalized treatments for patients and is run by the Wake Forest Baptist Comprehensive Cancer Center and the Wake Forest Institute for Regenerative Medicine.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.